This technology involves a recombinant Pichia pastoris strain that combines the human tyrosinase or tyrosinase-related protein 1 gene with an AOX1 promoter, alpha-mating factor signal sequence, Twin-Strep-tag, and TEV protease sequence, along with a method for high-purity purification using anion-exchange chromatography.
Most commercially available tyrosinases are mushroom-derived, which have low sequence homology with human enzymes and differ in catalytic activity and substrate specificity, limiting the accuracy of skin-whitening efficacy evaluations. E. coli expression systems cannot perform post-translational modifications, while insect larva systems are time-consuming and costly.
This technology uses a yeast secretory expression system to produce human-type tyrosinase and purifies it through anion-exchange columns and dialysis, securing high-purity enzymes at a lower cost and in less time. It can be applied to screening whitening cosmetic ingredients, researching pigmentary disorders like albinism, and enzyme structural analysis, enabling reliable efficacy evaluations based on human enzymes rather than mushroom enzymes.
This invention was developed with support from the Ministry of Education for research on the interaction between human GPCR sweet taste receptors and sweet substances, and for the development of new sweet materials.
N/A